SCHEMBL2521849

SCHEMBL2521849

CCc1c(CC)c(S(=O)(=O)O)c2ccccc2c1CC

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.35
SLC2A1 P11166 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
POLB P06746 2/20 0.33
KDM4E B2RXH2 2/20 0.33
APEX1 P27695 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NCEH1 Q6PIU2 1/20 0.33
PSIP1 O75475 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
TP53 P04637 1/20 0.31
TTR P02766 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL19137779 0.96 SLC2A1 (0.33) CYP2D6SLC2A1SMN1; SMN2TSHRHTT
SCHEMBL2521780 0.93 CYP2D6 (0.35) CYP2D6SLC2A1SMN1; SMN2TSHRHTT
SCHEMBL28551848 0.82 HTT (0.36) CYP2D6SMN1; SMN2TSHRHTTPOLB
SCHEMBL2865462 0.82 FABP3 (0.37) SMN1; SMN2TSHRPOLBKDM4EAPEX1
SCHEMBL565709 0.81 DAPK1 (0.36) CYP2D6SLC2A1SMN1; SMN2TSHRHTT
Lithium Ion SCHEMBL8645695 0.80 HTT (0.37) SMN1; SMN2HTTKDM4EPSIP1CES2
SCHEMBL18140261 0.80 CA12 (0.34) SMN1; SMN2HTTPOLBKDM4ETDP1
SCHEMBL2519819 0.79 KDM4E (0.41) CYP2D6SLC2A1SMN1; SMN2TSHRPOLB
SCHEMBL7779121 0.79 KDM4E (0.41) CYP2D6SLC2A1SMN1; SMN2TSHRHTT
Formaldehyde SCHEMBL18141073 0.77 CA12 (0.33) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180163056-A1 HYDROPHILIC CURABLE COMPOSITIONS MITSUI CHEMICALS, INC. (JP) 2018-06-14 US disclosed
US-20170209345-A1 DENTAL PROSTHESIS MITSUI CHEMICALS, INC. (JP) 2017-07-27 US disclosed
EP-2671903-A1 METHOD FOR PRODUCING RESIN FILM USING ELECTROCONDUCTIVE RESIN COMPOSITION Nitto Denko Corporation (JP) 2013-12-11 EP disclosed
US-20130320268-A1 METHOD FOR PRODUCING RESIN FILM USING ELECTROCONDUCTIVE RESIN COMPOSITION NITTO DENKO CORPORATION (JP) 2013-12-05 US disclosed
US-8039057-B2 Forming a polyimide compound containing a polymeric conductive agent into a film shape; exposing the film to high temperature and humidity FUJI XEROX CO., LTD. (JP) 2011-10-18 US disclosed
US-7812084-B2 Polyamic acid composition, production method thereof, polyimide resin, semiconductive member and image-forming apparatus FUJI XEROX CO., LTD. (JP) 2010-10-12 US disclosed
US-7593676-B2 Image-forming apparatus with improved intermediate transfer body FUJI XEROX CO., LTD. (JP) 2009-09-22 US disclosed
US-7569271-B2 Polyimide based compositions comprising doped polyaniline and methods and compositions relating thereto E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-04 US disclosed
US-20080280226-A1 Polyimide film, image-forming apparatus, method for producing the polyimide film, and method for producing the intermediate transfer belt FUJI XEROX CO., LTD. (JP) 2008-11-13 US disclosed
US-20080107457-A1 Image-forming apparatus FUJI XEROX CO., LTD. (JP) 2008-05-08 US disclosed
US-20080090091-A1 Polyimide Based Compositions Comprising Doped Polyaniline and Methods and Compositions Relating Thereto DUPONT ELECTRONICS, INC. 2008-04-17 US disclosed
US-20080081880-A1 Polyamic acid composition, production method thereof, polyimide resin, semiconductive member and image-forming apparatus FUJI XEROX CO., LTD. (JP) 2008-04-03 US disclosed
US-7316791-B2 Polyimide based substrate comprising doped polyaniline E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-01-08 US disclosed
US-20070025740-A1 Intermediate transfer belt, production method thereof, and image-forming device using the intermediate transfer belt FUJI XEROX CO., LTD. (JP) 2007-02-01 US disclosed
US-20050214554-A1 Polyimide film, image-forming apparatus, method for producing the polyimide film, and method for producing the intermediate transfer belt FUJI XEROX CO., LTD. (JP) 2005-09-29 US disclosed
EP-1553142-A2 Polyimide based compositions comprising doped polyaniline and methods relating thereto E.I. DU PONT DE NEMOURS AND COMPANY (US) 2005-07-13 EP disclosed
US-20050145832-A1 POLYIMIDE BASED COMPOSITIONS COMPRISING DOPED POLYANILINE AND METHODS AND COMPOSITIONS RELATING THERETO DUPONT ELECTRONICS, INC. 2005-07-07 US disclosed
US-5436796-A Polyaniline in undoped state, second polymer having ester or amide groups, protonic acid NITTO DENKO CORPORATION (JP) 1995-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209345-A1 DENTAL PROSTHESIS CAD, OR10J3, PSMA3 CYP2D6 3910/4885SLC2A1 3445/4885SMN1; SMN2 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.